Search results
'Practice Changing' Trial for Inoperable Locally Advanced NSCLC
MedPage Today· 4 days agoEGFR testing now needed for all patients with stage III disease, experts say
‘I can’t explain why’: Does this dog dewormer cure cancer? These Facebook groups say yes
The Daily Dot· 6 days agoThree months later, the cancer had grown. From a cattle farm in Louisiana where she’s helping a...
Markets News, June 3, 2024: Nasdaq Ticks Higher; Oil, Treasury Yields Tumble
Investopedia· 2 days agoU.S. stocks were mixed Monday, with weak manufacturing and construction data, as well as falling oil...
Domestic drug R&D makes positive strides
China Daily· 2 days agoDevelopment of innovative drugs in China has gathered momentum in recent years thanks to ramped-up research spending and the rollout of policies that facilitate international collaboration and ...
Some drugmakers to cap cost of asthma inhalers at $35 a month
NBC NEWS· 5 days agoStarting Saturday, the cost of inhalers will fall for many Americans, as new out-of-pocket price...
Deal Watch: Energy, Pharma Continue to Drive Deal Activity as Wachtell, Kirkland Lead $22.5 Billion...
Law.com· 3 days agoThe transaction is the latest in a series of consolidation moves in the energy sector, coming on the...
How ‘Selling Out’ helped psychedelic MDMA
San Jose Mercury News· 3 days agoRick Doblin first dreamed of the therapeutic potential of the psychedelic drug MDMA in a hippie house in downtown Santa Cruz, in an era when fears of bad...
U.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.30%
Investing.com· 3 days agoU.S. shares mixed at close of trade; Dow Jones Industrial Average down 0.30%
Chutes & Ladders—Roche veteran James Sabry hangs up his hat
FierceBiotech· 6 days agoPlease send the good word—or the bad—from your shop to Gabrielle Masson and it will be featured here...
Dow Likely To See Further Downside Amid Steep Drop By Salesforce
RTT News· 7 days agoThe major U.S. index futures are currently pointing to a lower open on Thursday, with the Dow futures showing a notable move to the downside. A steep drop by shares of Salesforce (CRM) is likely ...
